Evidence map›Paper›PMID 34974057›Full record

ArticleThe Journal of infection2022

Characteristics of  SARS-CoV-2 super-spreaders in Japan.

Tomoki Kawahara, Yutaka Ueki, Nobutoshi Nawa, Shigeru Miyamae, Mariko Hanafusa, Yuki Goto, Shuji Tohda, Takeo Fujiwara

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Tomoki KawaharaDepartment of Global Health Promotion, Tokyo Medical and Dental University, Tokyo, Japan.
Yutaka UekiTrauma and Acute Critical Care Medical Center, Tokyo Medical and Dental University, Tokyo, Japan.
Nobutoshi NawaDepartment of Medical Education Research and Development, Tokyo Medical and Dental University, Tokyo, Japan.
Shigeru MiyamaeDisaster Medical Care Office, Tokyo Medical and Dental University, Tokyo, Japan.
Mariko HanafusaDepartment of Global Health Promotion, Tokyo Medical and Dental University, Tokyo, Japan.
Yuki GotoDepartment of Global Health Promotion, Tokyo Medical and Dental University, Tokyo, Japan.
Shuji TohdaDepartment of Clinical Laboratory, Tokyo Medical and Dental Hospital, Tokyo Medical and Dental University, Tokyo, Japan.
Takeo FujiwaraDepartment of Global Health Promotion, Tokyo Medical and Dental University, Tokyo, Japan. Electronic address: fujiwara.hlth@tmd.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2HumansJapan

Identifiers

PMID34974057
PMCPMC8717706

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.